Evidence map›Paper›PMID 39124976›Full record

ArticleMolecules (Basel, Switzerland)2024

Improving the Solubility, Stability, and Bioavailability of Albendazole through Synthetic Salts.

Haiying Yan, Xueping Zhong, Yao Liu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haiying YanMedical College, Qinghai University, Xining 810001, China.
Xueping ZhongMedical College, Qinghai University, Xining 810001, China.
Yao LiuMedical College, Qinghai University, Xining 810001, China.

Funding

the science and technology of Qinghai Province No. 2022-ZJ-748
6 · The paper itself

Abstract

Albendazole (ABZ) is a highly effective yet poorly water-soluble antiparasitic drug known to form salts (ABZ-FMA, ABZ-DTA, and ABZ-HCl) with fumaric acid (FMA), D-tartaric acid (DTA), and hydrochloric acid (HCl). This research utilized a range of analytical techniques, including Fourier transform infrared spectroscopy (FT-IR), nuclear magnetic resonance hydrogen spectroscopy (

Indexed as

AlbendazoleBiological AvailabilityDrug StabilitySaltsSolubilityAnimalsCalorimetry, Differential ScanningSpectroscopy, Fourier Transform InfraredX-Ray DiffractionAlbendazoleSaltsalbendazoleoral bioavailabilitysaltsolid-state propertiessolubilitystability

Identifiers

PMID39124976
PMCPMC11314343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.